We are live on ! Find out more
VCM

Vivaldi Capital Management Portfolio holdings

AUM $723M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+30.89%
3 Year Est. Return
+69.18%
5 Year Est. Return
+67.82%
10 Year Est. Return
AUM
$343M
AUM Growth
+$9.34M
Cap. Flow
-$6.94M
Cap. Flow %
-2.02%
Top 10 Hldgs %
32.04%
Holding
236
New
17
Increased
64
Reduced
112
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 7.72%
2 Healthcare 3.57%
3 Financials 3.29%
4 Real Estate 2.91%
5 Consumer Discretionary 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DJUN icon
226
FT Vest US Equity Deep Buffer ETF June
DJUN
$353M
-14,929
Closed -$581K
IVW icon
227
iShares S&P 500 Growth ETF
IVW
$77.6B
-2,592
Closed -$209K
MCK icon
228
McKesson
MCK
$101B
-501
Closed -$253K
MDLZ icon
229
Mondelez International
MDLZ
$79.9B
-3,058
Closed -$220K
MUB icon
230
iShares National Muni Bond ETF
MUB
$45.5B
-1,990
Closed -$214K
PULS icon
231
PGIM Ultra Short Bond ETF
PULS
$18.3B
-17,515
Closed -$867K
T icon
232
AT&T
T
$163B
-11,561
Closed -$195K
THS
233
DELISTED
Treehouse Foods
THS
-5,532
Closed -$232K
TRI icon
234
Thomson Reuters
TRI
$44.1B
-1,477
Closed -$229K
VCIT icon
235
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
-2,695
Closed -$214K
WTW icon
236
Willis Towers Watson
WTW
$32B
-1,809
Closed -$490K

Similar funds

Vivaldi Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Vivaldi Capital Management held 236 positions worth $343M, up 2.8% from $333M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Vivaldi Capital Management's Q1 2024 filing shows 17 new, 64 increased, 112 reduced and 16 closed positions. Its largest new stake was LENZ Therapeutics: 58,752 shares worth $924K. The largest sale was Oracle, an estimated $1.4M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.

  • Vivaldi Capital Management's largest Q1 2024 buy was LENZ Therapeutics: 58,752 shares worth $924K.
  • Vivaldi Capital Management added most to BlackRock Credit Allocation Income Trust in Q1 2024, an estimated $1.12M increase.
  • Vivaldi Capital Management's biggest Q1 2024 reduction was Oracle, cutting an estimated $1.4M.
  • Vivaldi Capital Management fully exited PGIM Ultra Short Bond ETF in Q1 2024, selling an estimated $867K.
  • Vivaldi Capital Management's ten largest holdings make up 32% of its $343M portfolio in Q1 2024.
  • Vivaldi Capital Management opened 17 new positions and closed 16 in Q1 2024.
  • Vivaldi Capital Management's portfolio value rose 2.8% quarter-over-quarter to $343M.

Based on Vivaldi Capital Management's 13F filing for Q1 2024, filed 15 May 2024.